Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Waldencast Acquisition Corp. - Class A Ordinary Share (WALD)
Company Research
Source: GlobeNewswire
NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the recent American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place November 13–16, 2025, in Chicago, Illinois. Pivotal FDA Study Comparison of Two Hyaluronic Acid Fillers for Midface Augmentation and Associated Improvement in Nasolabial Folds Appearance led to Obagi Hyaluronic Acid Featured as a Top 10 Abstract Presented by Dr. Sue Ellen Cox: “As an investigator in this pivotal study, I was pleased that the data was recognized as one of the top 10 abstracts and selected for an oral presentation,” commented Dr. Sue Ellen Cox. “The data highlights the compelling results of the Obagi® saypha® ChIQ™ pivotal study and shows the potential of the product to provide high-level satisfaction for patients seeking long-lasting, natural-looking results.” Th
Show less
Read more
Impact Snapshot
Event Time:
WALD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WALD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WALD alerts
High impacting Waldencast Acquisition Corp. - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
WALD
News
- How Recent Developments Are Shaping the Waldencast Investment Story [Yahoo! Finance]Yahoo! Finance
- Waldencast (NASDAQ:WALD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $5.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- Waldencast (NASDAQ:WALD) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
- Waldencast (NASDAQ:WALD) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating.MarketBeat
- Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading UpdateGlobeNewswire
WALD
Sec Filings
- 12/4/25 - Form F-3
- 11/24/25 - Form 6-K
- 11/24/25 - Form 6-K
- WALD's page on the SEC website